Early detection and management of COPD. What you can do to reduce the impact of this disabling disease. - Wikidata - wikimedia - TriplyDB

Early detection and management of COPD. What you can do to reduce the impact of this disabling disease.

Early detection and management of COPD. What you can do to reduce the impact of this disabling disease.

http://www.wikidata.org/entity/Q34705576

about

Effectiveness of regular reporting of spirometric results combined with a smoking cessation advice by a primary care physician on smoking quit rate in adult smokers: a randomized controlled trial. ESPIROTAB study.Spirometric testing on World COPD Day Long-acting inhaled beta 2-agonists for stable COPD.A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol Budesonide-formoterol (inhalation powder) in the treatment of COPD.Does screening for loss of lung function help smokers give up?Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.Early intervention for chronic obstructive pulmonary disease by practice nurse and GP teams: a cluster randomized trial.

P2860

Q33943942-3D929042-2CE1-4276-A850-0160271BA47F Q34721283-C57DEEAC-DCB2-48EE-8C69-BEEE000FCDDF Q35201031-FC5E9FAF-585A-4D4F-BE1E-8843D833C087 Q36278452-3D0B5D18-BBD3-485B-A764-38D1149EF479 Q37018887-F16AC534-5830-4F87-9ACF-A64FD6111F34 Q44493684-B956B509-65B0-4A83-AA28-B69A7E1D3A39 Q46690776-24ECCF78-A7CC-438A-960D-D8D47B3B2B9E Q47673947-801B2FD8-8A3E-4BD0-9D8D-0647DE2B0ADB

P2860

Early detection and management of COPD. What you can do to reduce the impact of this disabling disease.

http://www.wikidata.org/entity/Q34705576

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Early detection and management ...... act of this disabling disease.

@ast

Early detection and management ...... act of this disabling disease.

@en

Early detection and management ...... act of this disabling disease.

@nl

type

label

Early detection and management ...... act of this disabling disease.

@ast

Early detection and management ...... act of this disabling disease.

@en

Early detection and management ...... act of this disabling disease.

@nl

prefLabel

Early detection and management ...... act of this disabling disease.

@ast

Early detection and management ...... act of this disabling disease.

@en

Early detection and management ...... act of this disabling disease.

@nl

P1433

Q34705576-8AF328EE-8CA9-45B6-9A21-F3ABF29C6BAE

P1476

Q34705576-E5591232-5FC7-427E-8788-AF1B466F3713

P2093

Q34705576-06B5D8DC-A2BD-4F24-9FD1-E829C083DF62

P2860

Q34705576-01844630-FCC4-42D0-BED7-2AF7FFFE8A12

Q34705576-159CA1B0-6D2A-4246-92A4-F25DFC8FE1BD

Q34705576-16F223EF-A878-47A1-B364-B8DCE94DFA50

Q34705576-3539EBD0-5088-4670-9E66-FEDF5A379F06

Q34705576-57CD8006-FFDF-4E68-8FD4-4825E27AA053

Q34705576-5B496475-702F-4848-9A77-7568E6522DA2

Q34705576-65CA4740-A714-4768-A3A4-321446FDEFAB

Q34705576-6C624F9F-5F81-4ED1-812B-BC5D0FC9D45D

Q34705576-7182CDC3-9507-425D-B30D-2341269EE8F5

Q34705576-79083389-883E-4594-B303-0A10AEC24764

P304

Q34705576-C9191645-4D4A-42DE-BAE5-DFC3BB9A07F8

P31

Q34705576-86A92C4A-AA45-48D0-ADED-F347DE52898B

P356

Q34705576-DE97C505-19E2-4F02-9C59-6625E202879A

P407

Q34705576-6B42EEF4-A935-4961-8C69-68D49D84950A

P433

Q34705576-057056A0-D1D3-469C-8B2A-BB8425688DB2

P478

Q34705576-B474F48A-5361-431E-862C-C8A530B695B0

P577

Q34705576-67FE42EC-8489-47D5-AA44-47301E382B64

P698

Q34705576-36C46F65-8A16-4568-8CE1-5734D6CC6FED

P921

Q34705576-57AA3B36-3A0A-4CAB-B777-02E9C1D89E28

P356

PGM.2002.06.1225

P1433

Postgraduate Medicine

P1476

Early detection and management ...... act of this disabling disease.

@en

P2093

Dennis E Doherty

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

The natural history of chronic airflow obstruction

Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers.

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.

P304

41-4, 49-50, 53 passim

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2002.06.1225

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12082920

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease